Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 282

1.

A Nationally Representative Study of Non-Index Hospital Readmissions Following Radical Prostatectomy: Implications for Bundled Payment Models.

Chappidi MR, Stimson CJ, Kates M, Odisho AY, Bivalacqua TJ.

J Urol. 2019 Sep 3:101097JU0000000000000522. doi: 10.1097/JU.0000000000000522. [Epub ahead of print]

PMID:
31479405
2.

An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle-invasive bladder cancer.

Daniels MJ, Barry E, Milbar N, Schoenberg M, Bivalacqua TJ, Sankin A, Kates M.

Urol Oncol. 2019 Aug 28. pii: S1078-1439(19)30299-6. doi: 10.1016/j.urolonc.2019.07.022. [Epub ahead of print]

PMID:
31473090
3.

Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer.

Joice GA, Bivalacqua TJ, Kates M.

Nat Rev Urol. 2019 Aug 21. doi: 10.1038/s41585-019-0220-4. [Epub ahead of print] Review.

PMID:
31434998
4.

Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer.

Kates M, Nirschl TR, Baras AS, Sopko NA, Hahn NM, Su X, Zhang J, Kochel CM, Choi W, McConkey DJ, Drake CG, Bivalacqua TJ.

Eur Urol Oncol. 2019 Feb 26. pii: S2588-9311(19)30025-2. doi: 10.1016/j.euo.2019.01.017. [Epub ahead of print]

PMID:
31411999
5.

Predictive biomarkers for drug response in bladder cancer.

Yoshida T, Kates M, Fujita K, Bivalacqua TJ, McConkey DJ.

Int J Urol. 2019 Aug 1. doi: 10.1111/iju.14082. [Epub ahead of print] Review.

PMID:
31370109
6.

Editorial Comment.

Kates M.

J Urol. 2019 Jul 9:10109701JU000057670056544da. doi: 10.1097/01.JU.0000576700.56544.da. [Epub ahead of print] No abstract available.

PMID:
31287762
7.

Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer.

Daniels MJ, Barry E, Schoenberg M, Lamm DL, Bivalacqua TJ, Sankin A, Kates M.

Urol Oncol. 2019 Jun 26. pii: S1078-1439(19)30218-2. doi: 10.1016/j.urolonc.2019.05.018. [Epub ahead of print]

PMID:
31255541
8.

Establishing the inter-rater reliability of spinal cord damage manual measurement using magnetic resonance imaging.

Cummins DP, Connor JR, Heller KA, Hubert JS, Kates MJ, Wisniewski KR, Berliner JC, O'Dell DR, Elliott JM, Weber KA 2nd, Smith AC.

Spinal Cord Ser Cases. 2019 Feb 18;5:20. doi: 10.1038/s41394-019-0164-1. eCollection 2019.

PMID:
31240117
9.

Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical.

Pederzoli F, Murati Amador B, Samarska I, Lombardo KA, Kates M, Bivalacqua TJ, Matoso A.

Hum Pathol. 2019 Aug;90:1-7. doi: 10.1016/j.humpath.2019.04.018. Epub 2019 May 6.

PMID:
31071342
10.

Adjuvant Therapy for Urothelial and Renal Cell Carcinoma.

Patel HD, Kates M, Allaf ME.

Eur Urol Focus. 2019 Apr 25. pii: S2405-4569(19)30123-3. doi: 10.1016/j.euf.2019.04.007. [Epub ahead of print]

PMID:
31031041
11.

Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.

Hassan O, Murati Amador B, Lombardo KA, Salles D, Cuello F, Marwaha AS, Daniels MJ, Kates M, Bivalacqua TJ, Matoso A.

World J Urol. 2019 Apr 27. doi: 10.1007/s00345-019-02782-y. [Epub ahead of print]

PMID:
31030230
12.

Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments.

Gupta M, Kates M, Bivalacqua TJ.

Curr Opin Oncol. 2019 May;31(3):183-187. doi: 10.1097/CCO.0000000000000533.

PMID:
30893148
13.

Discovery of VU2957 (Valiglurax): An mGlu4 Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's Disease.

Panarese JD, Engers DW, Wu YJ, Bronson JJ, Macor JE, Chun A, Rodriguez AL, Felts AS, Engers JL, Loch MT, Emmitte KA, Castelhano AL, Kates MJ, Nader MA, Jones CK, Blobaum AL, Conn PJ, Niswender CM, Hopkins CR, Lindsley CW.

ACS Med Chem Lett. 2018 Oct 16;10(3):255-260. doi: 10.1021/acsmedchemlett.8b00426. eCollection 2019 Mar 14.

PMID:
30891122
14.

Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer.

Brant A, Daniels M, Chappidi MR, Joice GA, Sopko NA, Matoso A, Bivalacqua TJ, Kates M.

World J Urol. 2019 Mar 8. doi: 10.1007/s00345-019-02673-2. [Epub ahead of print]

PMID:
30850856
15.

Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.

Gupta M, Milbar N, Tema G, Pederzoli F, Chappidi M, Kates M, VandenBussche CJ, Bivalacqua TJ.

World J Urol. 2019 Jan 23. doi: 10.1007/s00345-018-02624-3. [Epub ahead of print]

PMID:
30671639
16.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.

N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.

PMID:
30415628
17.

Midsagittal tissue bridges are associated with walking ability in incomplete spinal cord injury: A magnetic resonance imaging case series.

O'Dell DR, Weber KA, Berliner JC, Elliott JM, Connor JR, Cummins DP, Heller KA, Hubert JS, Kates MJ, Mendoza KR, Smith AC.

J Spinal Cord Med. 2018 Oct 22:1-4. doi: 10.1080/10790268.2018.1527079. [Epub ahead of print]

PMID:
30346248
18.

CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer.

Ooki A, VandenBussche CJ, Kates M, Hahn NM, Matoso A, McConkey DJ, Bivalacqua TJ, Hoque MO.

Br J Cancer. 2018 Oct;119(8):961-970. doi: 10.1038/s41416-018-0291-7. Epub 2018 Oct 17.

PMID:
30327565
19.

Editorial Comment.

Kates M, Bivalacqua TJ.

J Urol. 2018 Nov;200(5):1011-1012. doi: 10.1016/j.juro.2018.05.157. Epub 2018 Jul 29. No abstract available.

PMID:
30063891
20.

Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter?

Joice GA, Chappidi MR, Patel HD, Kates M, Sopko NA, Stimson CJ, Pierorazio PM, Bivalacqua TJ.

BJU Int. 2018 Dec;122(6):1016-1024. doi: 10.1111/bju.14448. Epub 2018 Jul 26.

PMID:
29897156

Supplemental Content

Loading ...
Support Center